XERS (XERIS BIOPHARMA HOLDINGS INC) is held by 0 tracked superinvestors with an aggregate position value of $0 based on the most recent SEC 13F filings. Top institutional holders include: see holder table.

How much XERS do superinvestors hold in aggregate?

Across 0 tracked managers, superinvestors collectively report $0 in XERS positions worth 0 shares.

What is the largest holder of XERS?

No tracked superinvestors currently hold XERS.

← Top Holdings

XERSXERIS BIOPHARMA HOLDINGS INC

CUSIP: 98422E103

No superinvestors currently hold this stock.

📊 Fundamentals

Market Cap$1.5B

P/E Ratio111.8x

Above market avg

Forward P/E22.6x

P/FCF36.6x

EPS (TTM)$0.08

Revenue (TTM)$314.9M

Profit Margin3.81%

Beta0.85

52-Week Range

$4.66

$10.08

Current: $8.94

Data from Yahoo Finance · refreshed every 4 hours

💡 Trades at 111.8x trailing earnings → 22.6x forward · 3.8% profit margin

📊 Holdings Over Time

How superinvestor ownership has changed across quarters

Quarter-by-Quarter Activity

Q4 '251 owners · $1.0M

INCREASEDPolen Capital$1.0M

Q3 '251 owners · $1.1M

INCREASEDPolen Capital$1.1M

Q2 '251 owners · $621K

NEWPolen Capital$621K

SOLDPrem Watsa

Q4 '241 owners · $472K

REDUCEDPrem Watsa$472K

Q3 '241 owners · $485K

No changes

Q2 '241 owners · $383K

INCREASEDPrem Watsa$383K

💰 DCF Calculator

DCF model · 10-yr forecast

Estimates depend entirely on your assumptions. Adjust the inputs below to explore scenarios.

📊 Adjust the assumptions below to calculate an estimated fair value

Projection Period

Revenue Growth Rate

23%analyst est. 22.5%

0%100%

Growth Decay Rate

15%

0% (no decay)50% (fast decay)

Terminal Growth Rate

3.0%

0%5%

FCF Margin

13.4%current: 13.4%

1%50%

Discount Rate (WACC)

8.0%typical: 8% large caps · 10% growth

5%20%

Model: 10-year DCF · 3.0% terminal growth · Based on Yahoo Finance data